Nanologica AB (publ) (STO:NICA)
0.3010
-0.0030 (-0.99%)
Sep 23, 2026, 9:21 AM CET
Nanologica AB Market Cap
Nanologica AB has a market cap or net worth of 99.95 million as of September 22, 2026. Its market cap has decreased by -4.56% in one year.
Market Cap
99.95M
Enterprise Value
134.52M
Revenue
129.48M
Ranking
n/a
PE Ratio
3.15
Stock Price
0.30
ChartMarket Cap Chart
Since October 30, 2015, Nanologica AB's market cap has increased from 73.54M to 99.95M, an increase of 35.90%. That is a compound annual growth rate of 2.85%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 23, 2026 | 99.95M | 45.00% |
| Dec 30, 2025 | 68.93M | -57.14% |
| Dec 30, 2024 | 160.81M | -57.22% |
| Dec 29, 2023 | 375.92M | 33.47% |
| Dec 30, 2022 | 281.66M | -27.01% |
| Dec 30, 2021 | 385.87M | 3.67% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Initiator Pharma | 149.91M |
| Simris Group AB (PUBL) | 139.70M |
| NextCell Pharma AB | 136.25M |
| Xintela AB | 135.65M |
| Active Biotech AB | 108.21M |
| Biovica International AB | 88.45M |
| Alzinova AB | 87.14M |
| Pila Pharma AB | 85.43M |